DANIEL EICHNER

Daniel Eichner is a distinguished Partner at SOSV, a prominent global venture capital firm recognized for its unique accelerator model and significant contributions to the deep tech and life sciences ecosystems. At SOSV, Daniel plays a crucial role in identifying, investing in, and scaling early-stage companies that are tackling some of the world's most pressing challenges through scientific and technological breakthroughs. His expertise is particularly concentrated on the intersection of biology, engineering, and hard technology, making him a key figure in the firm's investments in biotech, climate tech, and advanced manufacturing.

As a Partner, Daniel Eichner is deeply involved with SOSV's renowned accelerator programs, including IndieBio, which focuses on biotech and life sciences, and HAX, dedicated to hard tech startups. Through these platforms, he works closely with founders, providing strategic guidance, operational support, and access to critical resources needed to transform innovative scientific ideas into viable commercial products. His hands-on approach helps companies navigate the complex journey from laboratory discovery to market readiness, emphasizing robust scientific validation and scalable business models.

Daniel's career background is rooted in a strong foundation of scientific research and entrepreneurial experience. He holds a Ph.D. in Bioengineering from the University of California, Berkeley, where his doctoral work provided him with a deep understanding of complex biological systems and engineering principles. This academic rigor is complemented by his practical experience in the startup world, having been involved in various capacities with early-stage ventures before joining SOSV. This blend of scientific acumen and venture capital insight positions Daniel Eichner as a highly effective investor in the frontier technology space.

His investment focus at SOSV spans a wide array of sectors driven by scientific innovation. This includes novel therapeutics, sustainable agriculture, synthetic biology, advanced materials, robotics, and climate solutions. Daniel is particularly interested in companies that leverage cutting-edge research to create tangible products with significant societal and economic impact. While specific individual investments are often part of broader fund activities, his influence is evident across numerous successful startups emerging from IndieBio and HAX that are pushing the boundaries of what's possible in biotech and hard tech. Daniel Eichner continues to be a driving force behind SOSV's mission to invest in "deep tech for humanity," fostering a new generation of science-driven entrepreneurs.